Worth reading
64In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
7194
Millions of yen (year-on-year increase in operating profit)Wording
Conditional
How definitive the wording is.Contents of this document
Financial Results Presentation2025年2月期 第2四半期9 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales60,229 Millions of yen+46.9%
Operating profit17,146 Millions of yen+72.3%
Ordinary income20,574 Millions of yen+48.3%
Net income15,850 Millions of yen+61.2%
Results for the three months of the current quarter
Semiconductor-related equipment
24,475 Millions of yen
Analytical instruments
1,030 Millions of yen
FPD-related equipment
3,130 Millions of yen
Life science-related equipment
181 Millions of yen
Parts, repairs and other
2,122 Millions of yen
Full-year earnings forecast
Net Sales
120,784 Millions of yen
Semiconductor-related equipment
102,399 Millions of yen
Analytical instruments
3,841 Millions of yen
FPD-related equipment
6,511 Millions of yen
Life science-related equipment
1,300 Millions of yen
Parts, repairs and other
6,732 Millions of yen
Operating profit
31,617 Millions of yen
Ordinary income
31,518 Millions of yen
Profit attributable to owners of the parent
22,916 Millions of yen
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales49.9
Semiconductor-related equipment50.1
Analytical instruments35.5
FPD-related equipment52.1
Life science-related equipment25.7
Parts, repairs and other56.9
Operating profit54.2
Ordinary income65.3
Profit attributable to owners of the parent69.2
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
通期連結業績予想に変更なしBreakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
- Revenue Volatility7,361 Millions of yen
- Foreign Exchange Effects1,513 Millions of yen
- Personnel expenses-733 Millions of yen
- Research and development costs53 Millions of yen
- Other SG&A expenses-1,001 Millions of yen
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Exchange rate
Second-half forecast144 JPY/USD
First-half results152 JPY/USD
New initiatives
- ベトナム子会社の新工場建設（投資総額約330百万USD）
- Nanoverse Technologies, Ltd.の連結子会社化
- ローツェライフサイエンスによるジェノスタッフ社買収
Segment results
Semiconductor-related equipment
Net Sales
51,311 Millions of yen
Year on year against the same period last year+48.8%
Analytical instruments
Net Sales
1,362 Millions of yen
Year on year against the same period last year-10.4%
FPD-related equipment
Net Sales
3,392 Millions of yen
Year on year against the same period last year+97.8%
Life science-related equipment
Net Sales
334 Millions of yen
Year on year against the same period last year+118.7%
Parts, repairs and other
Net Sales
3,828 Millions of yen
Year on year against the same period last year+22.4%
Risk amount incorporated into the outlookThe amount representing the range of variation the company expects in its forecast.
ベトナム生産子会社の台風被害見込額
443 Millions of yen
Details工場建物、設備および棚卸資産等
Nanoverse社下期業績への影響見込み
35 Hundreds of millions of yen
Detailsのれん償却最大15億円、販管費約20億円
Orders received and order backlog
Semiconductor-related equipment
Orders received
53,467 Millions of yen
Order backlog
25,762 Millions of yen
Analytical instruments
Orders received
4,085 Millions of yen
Order backlog
787 Millions of yen
FPD-related equipment
Orders received
4,573 Millions of yen
Order backlog
344 Millions of yen
Number of employees
Consolidated4,121 People
The Company242 People
Record date2024年8月末
Capital expenditures
330 百万USDベトナム子会社の新工場投資総額
| Item | Details |
|---|---|
| Document type | Financial Results Presentation |
| Fiscal Period Covered | 2025年2月期 第2四半期 |
| Net Sales | 60,229 Millions of yen (YoY +46.9%) |
| Operating profit | 17,146 Millions of yen (YoY +72.3%) |
| Ordinary income | 20,574 Millions of yen (YoY +48.3%) |
| Net income | 15,850 Millions of yen (YoY +61.2%) |
| Results for the three months of the current quarter | Semiconductor-related equipment 24,475 Millions of yen / Analytical instruments 1,030 Millions of yen / FPD-related equipment 3,130 Millions of yen / Life science-related equipment 181 Millions of yen / Parts, repairs and other 2,122 Millions of yen |
| Full-year earnings forecast | Net Sales 120,784 Millions of yen / Semiconductor-related equipment 102,399 Millions of yen / Analytical instruments 3,841 Millions of yen / FPD-related equipment 6,511 Millions of yen / Life science-related equipment 1,300 Millions of yen / Parts, repairs and other 6,732 Millions of yen / Operating profit 31,617 Millions of yen / Ordinary income 31,518 Millions of yen / Profit attributable to owners of the parent 22,916 Millions of yen |
| Progress against full-year forecast | Net Sales 49.9 / Semiconductor-related equipment 50.1 / Analytical instruments 35.5 / FPD-related equipment 52.1 / Life science-related equipment 25.7 / Parts, repairs and other 56.9 / Operating profit 54.2 / Ordinary income 65.3 / Profit attributable to owners of the parent 69.2 |
| Self-assessment against the plan | 通期連結業績予想に変更なし |
| Segment results | Semiconductor-related equipment Net Sales 51,311 Millions of yen / yoy_pct 48.8 / Analytical instruments Net Sales 1,362 Millions of yen / yoy_pct -10.4 / FPD-related equipment Net Sales 3,392 Millions of yen / yoy_pct 97.8 / Life science-related equipment Net Sales 334 Millions of yen / yoy_pct 118.7 / Parts, repairs and other Net Sales 3,828 Millions of yen / yoy_pct 22.4 |
| Breakdown of Factors Affecting the Change | Factors Revenue Volatility / Amount 7,361 Millions of yen, Factors Foreign Exchange Effects / Amount 1,513 Millions of yen, Factors Personnel expenses / Amount -733 Millions of yen, Factors Research and development costs / Amount 53 Millions of yen, Factors Other SG&A expenses / Amount -1,001 Millions of yen |
| Number of employees | Consolidated 4,121 People / The Company 242 People / Record date 2024年8月末 |
| Assumptions Underlying the Business Outlook | Exchange rate Second-half forecast 144 JPY/USD / First-half results 152 JPY/USD |
| Risk amount incorporated into the outlook | ベトナム生産子会社の台風被害見込額 443 Millions of yen / Nanoverse社下期業績への影響見込み 35 Hundreds of millions of yen |
| Capital expenditures | 330 百万USD（ベトナム子会社の新工場投資総額） |
| Orders received and order backlog | Semiconductor-related equipment Orders received 53,467 Millions of yen / Order backlog 25,762 Millions of yen / Analytical instruments Orders received 4,085 Millions of yen / Order backlog 787 Millions of yen / FPD-related equipment Orders received 4,573 Millions of yen / Order backlog 344 Millions of yen |
| New initiatives | ベトナム子会社の新工場建設（投資総額約330百万USD）, Nanoverse Technologies, Ltd.の連結子会社化, ローツェライフサイエンスによるジェノスタッフ社買収 |
Items this document does not state (13)
Gross Profit MarginOperating profit marginSelling, general and administrative expensesKey KPIsUnit price and quantity metricsNumber of stores and locationsMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.半導体関連装置およびFPD関連装置の売上増加、ならびに円安による為替差益が増収増益の理由とされている。営業利益については、半導体関連装置の売上増加が主な増益要因と説明されている。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.